Literature DB >> 3916514

Effects of cyclosporine on renal function following orthotopic heart transplantation.

N McKenzie, P Keown, C Stiller, W Kostuk, C Campbell, F Keith.   

Abstract

The early and late nephrotoxicity of cyclosporine was examined in 23 orthotopic heart transplant recipients and two heart-lung transplant recipients up to four years after the operation. Cyclosporine was given orally pre-operatively and intravenously for the first two to five days after the operation. Subsequent daily oral therapy, in two divided doses, was adjusted to maintain serum trough levels in the range of 150 vg/ml to 200 vg/ml. By six months after the transplantation, the trough level was reduced to approximately 100 vg/ml. The mean pre-operative creatinine was 119 +/- 27 microM/L. After the operation there was transient oliguria in all patients, the mean peak creatinine (251 +/- 104 microM/L) occurring on days two to five. By day eight, creatinine (138 +/- 68 microM/L) was not significantly different from the pre-operative value. The maximal cyclosporine trough level (479 +/- 216 vg/ml) was also seen on days two to five and declined (195 +/- 53 vg/ml) on day ten. Despite the temporal association, linear regression analysis demonstrated no correlation between the early increase in creatinine and the cyclosporine level. There was, however, a correlation between the pre-operative creatinine and the peak post-operative creatinine. Two patients required dialysis but no death could be attributed to renal failure. By six months after the operation, serum creatinine had increased to 145 +/- 53 microM/ml and thereafter, with gradual reduction in cyclosporine dosage serum creatinine levels stabilized at 197 +/- 97 mu/mL at two years.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3916514

Source DB:  PubMed          Journal:  J Heart Transplant        ISSN: 0887-2570


  3 in total

Review 1.  Chronic renal insufficiency in heart transplant recipients: risk factors and management options.

Authors:  Francisco González-Vílchez; José Antonio Vázquez de Prada
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

Review 2.  Exercise and heart transplantation. A review.

Authors:  G Niset; L Hermans; P Depelchin
Journal:  Sports Med       Date:  1991-12       Impact factor: 11.136

3.  Urodilatin: a new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients.

Authors:  M Hummel; M Kuhn; A Bub; H Bittner; D Kleefeld; P Marxen; B Schneider; R Hetzer; W G Forssmann
Journal:  Clin Investig       Date:  1992-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.